Trials / Conditions / Childhood Atypical Teratoid/Rhabdoid Tumor

Childhood Atypical Teratoid/Rhabdoid Tumor

11 registered clinical trials studyying Childhood Atypical Teratoid/Rhabdoid Tumor.

Status	Trial	Sponsor	Phase
Terminated	Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumo NCT02684071	Nicklaus Children's Hospital f/k/a Miami Children's Hospital	Phase 2
Completed	Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or R NCT02444546	Mayo Clinic	Phase 1
Withdrawn	Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhab NCT01453465	Children's Oncology Group	—
Terminated	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS T NCT01088763	National Cancer Institute (NCI)	Phase 1
Completed	Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spi NCT01076530	National Cancer Institute (NCI)	Phase 1
Completed	ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors NCT00946335	National Cancer Institute (NCI)	Phase 1
Completed	Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treati NCT00653068	Children's Oncology Group	Phase 3
Completed	AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors NCT00326664	National Cancer Institute (NCI)	Phase 1
Completed	Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, NCT00217412	National Cancer Institute (NCI)	Phase 1
Completed	Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors NCT00100880	National Cancer Institute (NCI)	Phase 1
Completed	Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors NCT00919750	Children's Oncology Group	—